| Pharmaceutical Information |
| Drug Name |
Benzoin |
| Drug ID |
BADD_D00239 |
| Description |
Benzoin is a white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide, and is used in organic syntheses. This should not be confused with benzoin gum from STYRAX (see [DB11222]). Benzoin is an FDA-approved colour additive used for marking fruits and vegetables. |
| Indications and Usage |
No approved therapeutic indications. |
| Marketing Status |
approved; experimental |
| ATC Code |
Not Available |
| DrugBank ID |
DB14020
|
| KEGG ID |
D03091
|
| MeSH ID |
D001573
|
| PubChem ID |
8400
|
| TTD Drug ID |
D0Z5KQ
|
| NDC Product Code |
46414-8888; 66798-424 |
| UNII |
L7J6A1NE81
|
| Synonyms |
Benzoin | 2-hydroxy-1,2-diphenylethanone | 2 hydroxy 1,2 diphenylethanone |
|
| Chemical Information |
| Molecular Formula |
C14H12O2 |
| CAS Registry Number |
119-53-9 |
| SMILES |
C1=CC=C(C=C1)C(C(=O)C2=CC=CC=C2)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Erythema | 23.03.06.001 | - | - | - | | Pain | 08.01.08.004 | - | - | | | Pyrexia | 08.05.02.003 | - | - | | | Rash | 23.03.13.001 | - | - | - | | Skin irritation | 23.03.04.009 | - | - | - | | Swelling | 08.01.03.015 | - | - | - |
|
The 1th Page
1
Total 1 Pages
|
|
